Johnson and Johnson Net Worth
$435 Billion
Johnson and Johnson total assets: Johnson and Johnson is an American combination that has total assets of $435 billion. It is exceedingly difficult to stroll into a drug store, pharmacy, or supermarket, anyplace on the planet, without finding an item made by
Johnson and Johnson. The New Brunswick, New Jersey-based organization is in a real sense inseparable from non-prescription clinical items, and their numerous auxiliaries supply clinical gear and medications to various clinics and careful centers all over the planet. A portion of the organization's all the more broadly perceived items incorporate, Band-Aid, Tylenol, Neutrogena, Clean and Clear, and Acuvue. Chances are, you have at least one of their items in your restroom, or medication bureau, at the present time.
Johnson and Johnson were established in direct reaction to crafted by celebrated specialist and researcher, Joseph Lister, who clarified the temperances of disinfectant clinical practice in the last part of the 1800s. The Johnson siblings, of whom there were three, made their own line of careful swathes in 1885. By 1887, the organization had developed fundamentally, and they consolidated.
The administration of the organization was passed from one comparative to another for right around 80 years. Johnson and Johnson have reliably positioned as one of the most regarded organizations on the planet and is notable for its obligation to "green" fabricating. The organization's treatment of the 1982 Chicago Tylenol episode, wherein seven individuals kicked the bucket in the wake of ingesting Tylenol bound with cyanide, is held up to act as an illustration of how all makers ought to deal with the review of items. The organization has 230 auxiliaries and fabricates 108 unique product offerings. They at present utilize 117,900 individuals in 57 nations.
![]() |
Johnson and Johnson Net Worth | net worth of johnson and johnson |
Johnson and Johnson
Net Worth: $435 Billion
Nationality: American
Johnson and Johnson yearly/quarterly overall gain history and development rate from 2010 to 2022. Net gain can be characterized as an organization's net benefit or deficit after all incomes, pay things, and costs have been represented.
Johnson and Johnson net gain for the quarter finishing March 31, 2022, was $5.149B, a 16.91% decay year-over-year.
Johnson and Johnson total compensation for the year finishing March 31, 2022, was $19.830B, a 31.19% increment year-over-year.
Johnson and Johnson yearly overall gain for 2021 was $20.878B, a 41.89% increment from 2020.
Johnson and Johnson yearly overall gain for 2020 was $14.714B, a 2.68% downfall from 2019.
Johnson and Johnson yearly net gain for 2019 was $15.119B, a 1.16% decay from 2018.
2021 $20,878B,
2020 $14,714B,
2019 $15,119B,
2018 $15,297B,
2017 $1,300B,
2016 $16,540B,
2015 $15,409B.
2014 $16,323B,
2013 $13,831B,
2012 $10,853B,
2011 $9,672B,
2010 $13,334B,
0 Comments